Mahamaya Lifesciences Limited has submitted a regulatory disclosure to the BSE Limited Listing Compliance Department regarding an upcoming earnings call. The disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company will hold an earnings call to discuss H1FY27 financial results for the half year ended September 30, 2026. The call is scheduled for Thursday, November 19, 2026, at 04:00 PM Indian Standard Time.

The earnings call will feature the following management speakers:

  • Mr. Krishnamurthy (Chairman)
  • Mr. Krishnamurthy (Managing Director)
  • Mr. Prashant (Whole Time Director)
  • Mrs. Lalitha
  • Mr. Amarendra (Chief Financial Officer)

The document serves as formal intimation to the exchange for record-keeping purposes regarding this scheduled investor communication event.